Abstract: Disclosed herein are methods for treating, ameliorating, and/or preventing Alzheimer's Disease in a specific patient population using tramiprosate, valyl-3-amino-1-propanesulfonic acid, or a pharmaceutically acceptable salt thereof based upon a combination of APOE4 status and disease severity.
Type:
Grant
Filed:
September 9, 2016
Date of Patent:
December 7, 2021
Assignee:
Alzheon, Inc.
Inventors:
Susan Abushakra, Aidan Power, Martin Tolar, John Hey, Jeremy Yu, Petr Kocis
Abstract: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
Abstract: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
Abstract: Disclosed herein are methods and compositions for treating, ameliorating, and/or preventing Alzheimer's disease in ApoE4-postitive patients using particular compounds and compositions thereof.
Type:
Grant
Filed:
March 23, 2015
Date of Patent:
November 12, 2019
Assignee:
Alzheon, Inc.
Inventors:
Martin Tolar, John A. Hey, Petr Kocis, Jeremy Yu